626 participants
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2020-12-02
- Completion:
- 2028-10-31
Conditions
- Advanced Non-Small Cell Lung Cancer
- Metastatic Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet